Abselion
  • Product
  • Applications
    • Applications Overview
    • Antibody Quantification
    • AAV Quantification
  • News & Events
  • Resources
  • Company
    • About us
    • Our team
    • Careers
  • Contact us
Select Page
  • Product
  • Applications
    • Applications Overview
    • Antibody Quantification
    • AAV Quantification
  • News & Events
  • Resources
  • Company
    • About us
    • Our team
    • Careers
  • Contact us
  • Home
  • /
  • Resources

Resources

  • All
  • Application Note
  • Technical Note
  • Case Study
Evaluating Amperia for AAV Quantification at NHSBT: Strong Correlation with Automated ELISA &
Case Study

Evaluating Amperia for AAV Quantification at NHSBT: Strong Correlation with Automated ELISA

Apr 22, 2025
Efficient, accurate quantification of human antibodies in Cell Line Development, a comparison with BLI and SPR &
Application Note

Efficient, accurate quantification of human antibodies in Cell Line Development, a comparison with BLI and SPR

Nov 28, 2024
University of Manchester COEBP efficiently isolates 10x higher-producing CHO population using the Amperia RED system &
Case Study

University of Manchester COEBP efficiently isolates 10x higher-producing CHO population using the Amperia RED system

Nov 28, 2024
Fast, accurate, reliable AAV quantification using Amperia, a comparison with ELISA &
Technical Note

Fast, accurate, reliable AAV quantification using Amperia, a comparison with ELISA

Nov 21, 2024
Abselion

Protein Research Made Simple

93 Lawrence Weaver Road
Cambridge
CB3 0LE. UK

  • Follow

Quick links

Product

Application Overview

News & Events

Resources

About Us

Our Team

Careers at Abselion

Contact Us

Stay in touch

Be the first to know about our latest news and upcoming events.

Subscribe

© ABSELION. All Rights Reserved 2025. Privacy Policy | Cookie Policy

×

Stay in touch

Be the first to know about our latest news and events.

Please use your business email address
Abselion needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.
